Postendocarditis mitral valve aneurysm.
Mitral valve aneurysm is defined as a localized, thin-walled, saccular bulge of the mitral leaflet toward the left atrium. In this study, we report a case of mitral aneurysm of the posterior leaflet (scallop P3) secondary to primary mitral endocarditis in a patient who underwent prosthetic aortic valve replacement and coronary artery bypass graft.
Pederzolli
Nicola
N
Cardiac Surgery Unit, 'C. Poma' Hospital, Via Albertoni 1, 46100 Mantova, Italy. pednik@yahoo.it
Agostini
Francescob
F
Fiorani
Vinicioa
V
Tappainer
Ernestoa
E
Nocchi
Andrea
A
Manfredi
Jacopoa
J
Mantovani
Paola
P
Zogno
Mario
M
D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001024:Aortic Valve Stenosis / Q000601:surgery; D003131:Combined Modality Therapy; D001026:Coronary Artery Bypass; D004697:Endocarditis, Bacterial / Q000382:microbiology* / Q000628:therapy; D016984:Enterococcus faecium / Q000302:isolation & purification*; D006322:Heart Aneurysm / Q000000981:diagnostic imaging / Q000382:microbiology* / Q000628:therapy; D006350:Heart Valve Prosthesis / Q000009:adverse effects*; D019918:Heart Valve Prosthesis Implantation / Q000295:instrumentation*; D006801:Humans; D008297:Male; D008944:Mitral Valve Insufficiency / Q000382:microbiology* / Q000628:therapy; D016459:Prosthesis-Related Infections / Q000382:microbiology* / Q000628:therapy; D012086:Reoperation; D016896:Treatment Outcome; D014463:Ultrasonography
D000900:Anti-Bacterial Agents